A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms (REPLENISH)

NCT01942668 PHASE3 COMPLETED Results posted

This study will be a prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter trial of postmenopausal subjects with an intact uterus.

Details

Lead sponsor	TherapeuticsMD
Phase	PHASE3
Status	COMPLETED
Enrolment	1845
Start date	Mon Aug 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Menopause

Interventions

• Estradiol
• Progesterone
• Placebo

Countries

United States